A new fight is brewing over the Medicare drug price negotiation program after the Trump administration proposed to consider ...

Medicare inflation rebates fail to curb rising drug prices, highlighting the need for further policy action to control costs.

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Biden-era ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Medicare drug ...

A Trump administration proposal to consider another form of drugs for Medicare price cuts is spurring legal and policy ...

President Donald Trump’s One Big Beautiful Bill, signed into law last week, reintroduces broader exemptions for orphan drugs ...

Learn about the benefits that become permanent features of Medicare in 2026 and how they have been changed or updated since ...

Cancer survivors who received high-cost immunotherapies appear more likely to experience financial hardship, according to ...

Trump’s “big beautiful” bill will also affect the pharmaceutical industry, while AI startups have pulled in the majority of ...

Health groups led by the American Academy of Pediatrics filed a lawsuit against HHS Secretary Robert F. Kennedy Jr. on Monday ...

The House passed the “One Big Beautiful Bill Act” on July 3, which includes sweeping changes to healthcare and some pharma-related provisions.

Sen. Murkowski, I saw your pained reaction to the reporter who shared with you Sen. Rand Paul’s comment that your vote ...